Andreas Kremer
Esch-sur-Alzette, Luxembourg, Luxembourg
2 k abonnés
+ de 500 relations
À propos
Since May 2015 I am with ITTM S.A. a new company providing data integration, knowledge…
Activité
Expérience
Formation
-
Universität zu Köln
-
Ph.D. thesis entitled: "Analysis of the transcriptional regulation of the early he65 promoter by the baculoviral transactivator IE1"
Expériences de bénévolat
-
Treasurer and Secretary
FASCIATIVE (Fascia Network Initiative)
- 5 ans
Santé
http://fasciative.net/
Projets
-
mye-InfoBank: "Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer" (COST action CA20117)
The concerted activity of these experts on myeloid cell biology (either basic or clinical research) MYE, bioinformatics INFO, and bio-banking BANK, will transform complex molecular information into standardised and applicable biomarkers, which have the potential to improve clinical decision making in a number of socio-economically important diseases.
-
Numerous IMI/IHI and H2020/Horizon Europe grant projects
For project details please see: https://orcid.org/0000-0003-1466-0600
-
CHARME: "Harmonising standardisation strategies to increase efficiency and competitiveness of European life-science research“ (COST action CA15110)
-
The COST Action CHARME aims to bridge and combine the fragmented areas to achieve a breakthrough in standardisation efforts. CHARME will identify needs and gaps, teaming up with other initiatives and organisations to avoid duplication and overlap of standardisation activities. Only through a common, coordinated, long-term strategy, by the active involvement of all stakeholders (from research, industry and policy), can standards be successfully assimilated into the daily workflow and thus…
The COST Action CHARME aims to bridge and combine the fragmented areas to achieve a breakthrough in standardisation efforts. CHARME will identify needs and gaps, teaming up with other initiatives and organisations to avoid duplication and overlap of standardisation activities. Only through a common, coordinated, long-term strategy, by the active involvement of all stakeholders (from research, industry and policy), can standards be successfully assimilated into the daily workflow and thus increase efficiency and competitiveness of European life-science research.
Langues
-
English
Bilingue ou langue natale
-
Dutch
Notions
-
Italian
Notions
-
German
Bilingue ou langue natale
Organisations
-
HE:AL campus
Scintific Advisory Committee
- aujourd’hui -
ISO
National Expert
- aujourd’huiExpert for ISO TC 276 (Biotechnology), ISO TC 215 Health Informatics, ISO IEC JTC 1/SC 42 "Artificial Intelligence"
-
i2b2 tranSMART
Member of the Board of Directors
-The i2b2 tranSMART Foundation is a member-driven non-profit foundation developing an open-source / open-data community around the i2b2 and tranSMART translational research platforms. The i2b2 tranSMART Foundation enables effective collaboration for precision medicine, through the sharing, integration, standardization and analysis of heterogeneous data from healthcare and research; through engagement and mobilization of a life science focused open-source, open-data community.
Autres profils similaires
Autres personnes nommées Andreas Kremer
-
Andreas Kremer
Partner at McKinsey & Company I CEO Risk Dynamics I Risk analytics I AI trust I Digital I Model risk management
-
Andreas Kremer
Vice President SWIFT Messaging bei Deutsche Bank
-
Andreas Kremer
Vertriebsleitung Europa bei Sigmian GmbH
-
Andreas Kremer
-
Andreas Kremer
76 autres personnes nommées Andreas Kremer sont sur LinkedIn
Autres personnes nommées Andreas Kremer